PF-06423264

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-06423264, covering 2017-06-21 to 2017-06-21. Get the full timeline:

Most recent: Clinical Trial Update: Topical Multiple Ascending Dose Study for PF-06423264 [Phase 1]